Skip to main content

Agilent's Bid to Acquire Stratagene Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, April 6.
1. Agilent to Buy Stratagene for $246M, CEO Sorge Plans Molecular Dx Spin-Off (from April 6)
2. Fraser-Liggett to Start New Genomics Institute at UMB Biopark (from April 5)
3. PerkinElmer Acquires Imaging Company Improvision to Expand HCS Business (from April 2)
4. Nanogen Lands GSA Contract, Opens Way for New Gov't Deals; Shares Surge 33 Percent (from April 4)
5. Roche, Swiss Non-profit Team to Study IVD Use in Developing Countries (from April 3)
The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.